233 related articles for article (PubMed ID: 36788421)
1. Updates on Organoid Model for the Study of Liver Cancer.
El-Khobar KE; Sukowati CHC
Technol Cancer Res Treat; 2023; 22():15330338231154090. PubMed ID: 36788421
[TBL] [Abstract][Full Text] [Related]
2. Organoids as research models for hepatocellular carcinoma.
Yu JH; Ma S
Exp Cell Res; 2022 Feb; 411(1):112987. PubMed ID: 34942189
[TBL] [Abstract][Full Text] [Related]
3. Plasma-derived extracellular matrix for xenofree and cost-effective organoid modeling for hepatocellular carcinoma.
El-Derby AM; Khedr MA; Ghoneim NI; Gabr MM; Khater SM; El-Badri N
J Transl Med; 2024 May; 22(1):487. PubMed ID: 38773585
[TBL] [Abstract][Full Text] [Related]
4. Organoid Models of Human Liver Cancers Derived from Tumor Needle Biopsies.
Nuciforo S; Fofana I; Matter MS; Blumer T; Calabrese D; Boldanova T; Piscuoglio S; Wieland S; Ringnalda F; Schwank G; Terracciano LM; Ng CKY; Heim MH
Cell Rep; 2018 Jul; 24(5):1363-1376. PubMed ID: 30067989
[TBL] [Abstract][Full Text] [Related]
5. Heterogeneity, inherent and acquired drug resistance in patient-derived organoid models of primary liver cancer.
Xian L; Zhao P; Chen X; Wei Z; Ji H; Zhao J; Liu W; Li Z; Liu D; Han X; Qian Y; Dong H; Zhou X; Fan J; Zhu X; Yin J; Tan X; Jiang D; Yu H; Cao G
Cell Oncol (Dordr); 2022 Oct; 45(5):1019-1036. PubMed ID: 36036881
[TBL] [Abstract][Full Text] [Related]
6. A Hepatocellular Cancer Patient-derived Organoid Xenograft Model to Investigate Impact of Liver Regeneration on Tumor Growth.
Haak F; Hess GF; Sedlaczek P; Soysal SD; Vosbeck J; Piscuoglio S; Coto-Llerena M; Kollmar O
J Vis Exp; 2024 Feb; (204):. PubMed ID: 38372340
[TBL] [Abstract][Full Text] [Related]
7. Modeling liver cancer and therapy responsiveness using organoids derived from primary mouse liver tumors.
Cao W; Liu J; Wang L; Li M; Verstegen MMA; Yin Y; Ma B; Chen K; Bolkestein M; Sprengers D; van der Laan LJW; Doukas M; Kwekkeboom J; Smits R; Peppelenbosch MP; Pan Q
Carcinogenesis; 2019 Mar; 40(1):145-154. PubMed ID: 30289434
[TBL] [Abstract][Full Text] [Related]
8. Liver organoids: a promising three-dimensional model for insights and innovations in tumor progression and precision medicine of liver cancer.
Chen Y; Liu Y; Chen S; Zhang L; Rao J; Lu X; Ma Y
Front Immunol; 2023; 14():1180184. PubMed ID: 37334366
[TBL] [Abstract][Full Text] [Related]
9. The phosphatidylethanolamine biosynthesis pathway provides a new target for cancer chemotherapy.
Guan Y; Chen X; Wu M; Zhu W; Arslan A; Takeda S; Nguyen MH; Majeti R; Thomas D; Zheng M; Peltz G
J Hepatol; 2020 Apr; 72(4):746-760. PubMed ID: 31760071
[TBL] [Abstract][Full Text] [Related]
10. Cancer-Associated Fibroblasts Provide a Stromal Niche for Liver Cancer Organoids That Confers Trophic Effects and Therapy Resistance.
Liu J; Li P; Wang L; Li M; Ge Z; Noordam L; Lieshout R; Verstegen MMA; Ma B; Su J; Yang Q; Zhang R; Zhou G; Carrascosa LC; Sprengers D; IJzermans JNM; Smits R; Kwekkeboom J; van der Laan LJW; Peppelenbosch MP; Pan Q; Cao W
Cell Mol Gastroenterol Hepatol; 2021; 11(2):407-431. PubMed ID: 32932015
[TBL] [Abstract][Full Text] [Related]
11. Generation of matched patient-derived xenograft in vitro-in vivo models using 3D macroporous hydrogels for the study of liver cancer.
Fong ELS; Toh TB; Lin QXX; Liu Z; Hooi L; Mohd Abdul Rashid MB; Benoukraf T; Chow EK; Huynh TH; Yu H
Biomaterials; 2018 Mar; 159():229-240. PubMed ID: 29353739
[TBL] [Abstract][Full Text] [Related]
12. Liver organoids: an in vitro 3D model for liver cancer study.
Dong R; Zhang B; Zhang X
Cell Biosci; 2022 Sep; 12(1):152. PubMed ID: 36085085
[TBL] [Abstract][Full Text] [Related]
13. Generation of expandable human pluripotent stem cell-derived hepatocyte-like liver organoids.
Mun SJ; Ryu JS; Lee MO; Son YS; Oh SJ; Cho HS; Son MY; Kim DS; Kim SJ; Yoo HJ; Lee HJ; Kim J; Jung CR; Chung KS; Son MJ
J Hepatol; 2019 Nov; 71(5):970-985. PubMed ID: 31299272
[TBL] [Abstract][Full Text] [Related]
14. NFκB activation demarcates a subset of hepatocellular carcinoma patients for targeted therapy.
Ramesh V; Selvarasu K; Pandian J; Myilsamy S; Shanmugasundaram C; Ganesan K
Cell Oncol (Dordr); 2016 Dec; 39(6):523-536. PubMed ID: 27562587
[TBL] [Abstract][Full Text] [Related]
15. Organoid Cultures Derived From Patients With Papillary Thyroid Cancer.
Chen D; Tan Y; Li Z; Li W; Yu L; Chen W; Liu Y; Liu L; Guo L; Huang W; Zhao Y
J Clin Endocrinol Metab; 2021 Apr; 106(5):1410-1426. PubMed ID: 33524147
[TBL] [Abstract][Full Text] [Related]
16. 3D human liver organoids: An in vitro platform to investigate HBV infection, replication and liver tumorigenesis.
Rao S; Hossain T; Mahmoudi T
Cancer Lett; 2021 May; 506():35-44. PubMed ID: 33675983
[TBL] [Abstract][Full Text] [Related]
17. Development and Optimization of A Human Hepatocellular Carcinoma Patient-Derived Organoid Model for Potential Target Identification and Drug Discovery.
Zhang CY; Zhang XF; Yuan J; Gong YF; Tang H; Guo WY; Li TY; Li CW; Tang YQ; Ma NF; Liu M
J Vis Exp; 2023 Aug; (198):. PubMed ID: 37607105
[TBL] [Abstract][Full Text] [Related]
18. Hedgehog signaling promotes sorafenib resistance in hepatocellular carcinoma patient-derived organoids.
Wang S; Wang Y; Xun X; Zhang C; Xiang X; Cheng Q; Hu S; Li Z; Zhu J
J Exp Clin Cancer Res; 2020 Jan; 39(1):22. PubMed ID: 31992334
[TBL] [Abstract][Full Text] [Related]
19. Establishment of 2.5D organoid culture model using 3D bladder cancer organoid culture.
Abugomaa A; Elbadawy M; Yamanaka M; Goto Y; Hayashi K; Mori T; Uchide T; Azakami D; Fukushima R; Yoshida T; Shibutani M; Yamashita R; Kobayashi M; Yamawaki H; Shinohara Y; Kaneda M; Usui T; Sasaki K
Sci Rep; 2020 Jun; 10(1):9393. PubMed ID: 32523078
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis B virus infection modeling using multi-cellular organoids derived from human induced pluripotent stem cells.
Cao D; Ge JY; Wang Y; Oda T; Zheng YW
World J Gastroenterol; 2021 Aug; 27(29):4784-4801. PubMed ID: 34447226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
